Post-approval studies (Phase 4)UnknownNCT02020161What this trial is testingClinical Guidelines for APL TreatmentWho this might be right forAPL PETHEMA Foundation 200
Testing effectiveness (Phase 2)UnknownNCT03624270What this trial is testingOral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic LeukaemiaWho this might be right forAcute Promyelocytic Leukemia The University of Hong Kong 60
Testing effectiveness (Phase 2)Ended earlyNCT01465386What this trial is testingBortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in RemissionWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Myeloblastic Leukemia Without Maturation (M1)+9 more Fred Hutchinson Cancer Center 6
Not applicableEnded earlyNCT00185523What this trial is testingAllogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)Who this might be right forLeukemia, Lymphocytic, AcuteLeukemiaLeukemia Acute Promyelocytic Leukemia (APL)+4 more Stanford University 88
Early research (Phase 1)Study completedNCT01588015What this trial is testingVaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more City of Hope Medical Center 36
Early research (Phase 1)Study completedNCT00015925What this trial is testingMS-275 in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT00002231What this trial is testingSafety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative VolunteersWho this might be right forHIV InfectionsHIV Seronegativity Wyeth-Lederle Vaccines
Not applicableStudy completedNCT00053157What this trial is testingSargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more Roswell Park Cancer Institute 10
Large-scale testing (Phase 3)Ended earlyNCT01132547What this trial is testingCyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerWho this might be right forCancer University of South Florida 22
Testing effectiveness (Phase 2)Ended earlyNCT00555048What this trial is testingAlemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more Fred Hutchinson Cancer Center 1
Early research (Phase 1)Study completedNCT00083070What this trial is testingTemozolomide in Treating Young Patients With Refractory or Recurrent LeukemiaWho this might be right forLeukemia Children's Oncology Group 16
Testing effectiveness (Phase 2)Study completedNCT00588809What this trial is testingSelumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)Myelodysplastic Syndromes+3 more National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)Study completedNCT00276601What this trial is testingCombination Chemotherapy in Treating Patients With Acute Promyelocytic LeukemiaWho this might be right forLeukemia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00520208What this trial is testingSafety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APLWho this might be right forAcute Promyelocytic Leukemia CytRx 15
Early research (Phase 1)Study completedNCT01123655What this trial is testingPhase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis PatientsWho this might be right forRheumatoid Arthritis VA Office of Research and Development 22
Testing effectiveness (Phase 2)Ended earlyNCT00184054What this trial is testingTrial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous LeukemiaWho this might be right forAcute Myelogenous Leukemia University of Southern California 11
Large-scale testing (Phase 3)Not Yet RecruitingNCT07296445What this trial is testingA Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)Who this might be right forAcute Promyelocytic Leukemia (APL)Acute Promyelocytic LeukaemiaAcute Promyelocytic Leukemia With PML-RARA+6 more SDK Therapeutics, Inc. 120
Not applicableNo Longer AvailableNCT02312037What this trial is testingExpanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative TherapyWho this might be right forCD33 Positive Acute Myelogenous Leukemia Pfizer
Large-scale testing (Phase 3)Study completedNCT00003883What this trial is testingItraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 578
Not applicableWithdrawnNCT02540057What this trial is testingFCR or APL in LRTI - A Single Surgeon Randomized Controlled TrialWho this might be right forOsteoarthritis Nova Scotia Health Authority